Blue Bear Ventures

Blue Bear Ventures Research Document Executive Summary Blue Bear Ventures (BBV), now evolving into Transitions First (T1ST) , is a seed-stage venture capital firm focused on deep technology startups founded by scientists and engineers from top research institutions. The firm specializes in companies at the intersection of health, climate, advanced materials, and manufacturing technologies, with particular emphasis on breakthrough innovations emerging from UC Berkeley, UCSF, MIT, and Stanford. Investment Thesis Blue Bear Ventures engages founders working on the frontiers of science and technology with the ambition to solve the most pressing challenges we face in the world today. The firm believes that the most important aspect of deep tech companies is the founding team—they invest in co-founding teams with the right combination of technical skills and entrepreneurial spirit, not just ideas or solo founders. The firm is transitioning into Transitions First , which broadens focus to "accelerating industrial transitions to scale" by supporting founders who are sustainably transforming manufacturing and production to meet future demands. Despite significant venture funding in climate tech, vital sectors of industry and food (responsible for 56% of greenhouse gas emissions) receive only 21% of funding—representing a $3 trillion opportunity. Investment Focus Areas Primary Sectors (Legacy BBV): Applied Biology : Gene therapy, synthetic biology, cell therapies, protein assays Climate & Clean Energy : Battery technology, solar, energy infrastructure, environmental monitoring Emerging Technology : Optical interconnects, AI/ML applications, advanced semiconductors Advanced Materials : Nanomaterial coatings, innovative material compositions Healthcare : Respiratory disease management, precision medicine, diagnostics Expanded Focus (Transitions First): Net-Zero Compliant Supply Chains : Technologies enabling localized, modular industrial production Sustainable Petrochemical Alternatives : Bio-manufacturing and synthetic biology at scale Circular Economy : Novel technologies creating value from waste streams across all industrial sectors Stage & Check Size Stage Focus : Seed stage investments, with occasional pre-seed and Series A follow-ons Check Size Range : $100,000 - $400,000 (seed-stage typical range) Ownership Target : Typically build meaningful positions in early-stage companies BBV focuses exclusively on early-stage companies and maintains reserves for follow-on investments in portfolio companies. They prefer to be the first institutional investor and typically lead or co-lead seed rounds. Recent Activity & Fund Status Recent Portfolio Developments (2024-2025): February 2025 : Resynergi (portfolio company) secured $18M Series B extension for plastic recycling innovation December 2024 : Ayar Labs (portfolio company) secured $155M Series D with investments from AMD, Intel Capital, NVIDIA for optical interconnects August 2024 : Cypris Materials recognized for sustainability initiatives Ongoing : Active support for portfolio companies through Transitions First partnership with BCG for corporate-founder collaboration Fund Status: Actively Deploying - Blue Bear Ventures is actively making new investments and supporting existing portfolio companies. Portfolio has generated notable wins (Ayar Labs' Series D raise, 90% survival rate across 60+ companies, $1B+ aggregate value created). Portfolio Overview Blue Bear Ventures has invested in 60+ startups with approximately $1B+ in cumulative value. Key portfolio companies include: Major Portfolio Companies: Ayar Labs - Optical interconnects for data centers (raised $155M Series D, Dec 2024) Aluna - Respiratory disease management platform (raised $15.3M Series B) Coreshell Technologies - Nanolayer coatings for batteries GenEdit - Gene therapy delivery systems DNA Lite - Oral gene therapies Clarity - High-density air quality monitoring Aether Bio - Enzyme engineering for biological manufacturing BioAmp Diagnostics - Rapid antibiotic resistance diagnostics Correlia Biosystems - High-throughput protein assays ImpriMed - Precision medicine for pet cancer Unnatural Products - Drug discovery platform for macrocyclic peptides YourChoice Therapeutics - Hormone-free contraceptives Resynergi - Advanced plastic recycling (Transitions First, raised $18M Series B Extension, Feb 2025) Ruby Bio - Bio-based manufacturing (Transitions First) AgriLoops - Sustainable aquaponics (Transitions First, Europe) New Sun Road - Modular smart grid management EngageLively - Interactive content creation mFluidx - Rapid DNA testing Numericcal - Deep neural network optimization Synkrino Bio - AI-driven inflammation treatment Portfolio Statistics: 60+ companies invested, advised, or launched $1B+ aggregate value created 90% survival rate across portfolio 2 documented exits Team & Philosophy Blue Bear Ventures is led by Marianne Abib-Pech and Alic Chen (Managing Partners), with Patrick Scaglia as Founding Partner/Chairman. Additional team includes Linda Maduwura (CFO), Irfan Vissandjee (Principal), and Deepak Gupta (General Partner), plus venture partners Daniel Fidler, Joanna Ridgway, and Kasra Pezeshki. BBV places exceptional emphasis on founding teams: Co-founder focused : Invest in co-founding teams, not solo founders Technical depth : Founders are scientists and engineers from top research institutions (UC Berkeley, UCSF, MIT, Stanford, Caltech, Colorado State, Harvard, University of Minnesota) Mentorship approach : Partners serve as confidants and mentors, not just capital providers Long-term commitment : Commitment to guide companies through "entire journey," not just early stages Embedded support : Partners provide clarity on strategy while respecting founder autonomy Founder Preferences Type of Founders Backed : Scientists and engineers from top research institutions Co-founding teams (not solo founders) - critical requirement Technical founders with deep domain expertise Lab-based founders with research pedigree Founders committed to solving major world challenges What They Look For : Breakthrough enabling technologies with clear path to cost-parity Non-disruptive implementation of transformative technology Coachable founders willing to accept mentorship Teams combining technical depth with entrepreneurial spirit Founders building companies for impact What They Avoid : Solo founders without co-founding team Abstract ideas without technical proof points Disruptive technologies requiring market wholesale transformation Non-technical founding teams Pure software without deep tech component Key Differentiators Deep Tech Focus : Exclusively invests in science and engineering-based companies Co-Founder Requirement : Unique emphasis on multi-founder teams from research labs Academic Network : Direct access to UC Berkeley CITRIS, top research institutions Long-Term Mentorship : Partners act as embedded team members, not passive investors Industry Expertise : Team has 30+ years in tech manufacturing, advanced materials, healthcare Corporate Bridge : BCG partnership creates unique access to corporate partnerships and scaling Global Innovation Ecosystems : T1ST expansion brings international deep tech focus Impact-Driven : Focus on solving major challenges (sustainability, health, climate) Conclusion Blue Bear Ventures is a specialized, thesis-driven seed-stage venture firm with exceptional technical depth and a unique focus on co-founder teams from top research institutions. The transition to Transitions First represents an evolution toward broader industrial transformation while maintaining core commitments to deep tech, scientist-founders, and long-term mentorship. The firm is particularly valuable for co-founding teams from research labs seeking patient capital, deep technical mentorship, and access to UC Berkeley's innovation ecosystem and BCG's corporate networks.